ZEB1-Factor increases chances of success of immunotherapy
Factor in connective tissue cells (ZEB1) modulates the efficacy of immunotherapy in colorectal carcinomas
Using the tumour microenvironment to improve therapy efficacy
Recent publication in Nature Reviews Cancer
audit berufundfamilie (work and familiy)
Georg Speyer House certified for the second time
»Impressive contributions to tumor research«
The German Science and Humanities Council (Wissenschaftsrat) certifies the Georg-Speyer-Haus high expertise in research and…
Florian Greten is listed as Highly Cited Researcher 2023
Florian Greten, Director of the Georg-Speyer-Haus and speaker of the LOEWE Centre Frankfurt Cancer Institute is 2023 amongst the…
Henner Farin receives funding through the DFG Heisenberg Program
The Georg-Speyer-Haus scientist is accepted into the Heisenberg Program of the German Research Foundation (DFG)